Found: 5000
Select item for more details and to access through your institution.
Integration of deep learning and habitat radiomics for predicting the response to immunotherapy in NSCLC patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 8, p. 1, doi. 10.1007/s00262-024-03724-3
- By:
- Publication type:
- Article
Two nomograms constructed for predicting the efficacy and prognosis of advanced non‑small cell lung cancer patients treated with anti‑PD‑1 inhibitors based on the absolute counts of lymphocyte subsets.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 8, p. 1, doi. 10.1007/s00262-024-03738-x
- By:
- Publication type:
- Article
Oligo-residual disease in PD-1/PD-L1 inhibitor-treated metastatic non-small cell lung cancer: incidence, pattern of failure, and clinical value of local consolidative therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 8, p. 1, doi. 10.1007/s00262-024-03720-7
- By:
- Publication type:
- Article
Longitudinal quality of life after sublobar resection and stereotactic body radiation therapy for early‐stage non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 14, p. 2515, doi. 10.1002/cncr.35286
- By:
- Publication type:
- Article
Chemoradiotherapy versus surgery after neoadjuvant chemoimmunotherapy in patients with stage III NSCLC: a real-world multicenter retrospective study.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03696-4
- By:
- Publication type:
- Article
miR‐29b‐3p targetedly regulates VEGF to inhibit tumor progression and cisplatin resistance through Nrf2/HO‐1 signaling pathway in non‐small cell lung cancer.
- Published in:
- Environmental Toxicology, 2024, v. 39, n. 7, p. 3956, doi. 10.1002/tox.24253
- By:
- Publication type:
- Article
High expression of AlkB homolog 5 suppresses the progression of non‐small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11.
- Published in:
- Environmental Toxicology, 2024, v. 39, n. 7, p. 4035, doi. 10.1002/tox.24272
- By:
- Publication type:
- Article
Preoperative evaluation of mediastinal lymph nodes in non-small cell lung cancer using [<sup>68</sup>Ga]FAPI-46 PET/CT: a prospective pilot study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 8, p. 2409, doi. 10.1007/s00259-024-06669-y
- By:
- Publication type:
- Article
Detection of PD‑L1 expression and epithelial‑mesenchymal transition of circulating tumor cells in non‑small cell lung cancer.
- Published in:
- Experimental & Therapeutic Medicine, 2024, v. 28, n. 1, p. N.PAG, doi. 10.3892/etm.2024.12583
- By:
- Publication type:
- Article
[Retracted] Long non‑coding RNA receptor activator of nuclear factor‑κB ligand promotes cisplatin resistance in non‑small cell lung cancer cells.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Safety of nivolumab monotherapy in five cancer types: pooled analysis of post-marketing surveillance in Japan.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 932, doi. 10.1007/s10147-024-02515-1
- By:
- Publication type:
- Article
Amide Proton Transfer‐Weighted Imaging and Multiple Models Intravoxel Incoherent Motion‐Based <sup>18</sup>F‐FDG PET/MRI for Predicting Progression‐Free Survival in Non‐Small Cell Lung Cancer.
- Published in:
- Journal of Magnetic Resonance Imaging, 2024, v. 60, n. 1, p. 125, doi. 10.1002/jmri.29037
- By:
- Publication type:
- Article
Editorial for "Amide Proton Transfer‐Weighted Imaging and Multiple Models Intravoxel Incoherent Motion Based <sup>18</sup>F‐FDG PET/MRI for Predicting Progression‐Free Survival in Non‐Small Cell Lung Cancer".
- Published in:
- 2024
- By:
- Publication type:
- Editorial
[Retracted] MicroRNA‑219 is downregulated in non‑small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
NKX2‑1 copy number alterations are associated with oncogenic, immunological and prognostic remodeling in non‑small cell lung cancer.
- Published in:
- Oncology Letters, 2024, v. 28, n. 1, p. N.PAG, doi. 10.3892/ol.2024.14436
- By:
- Publication type:
- Article
Administration of flurbiprofen axetil and dezocine for the postoperative analgesia in patients with non‑small cell lung cancer: A randomized, controlled study.
- Published in:
- Oncology Letters, 2024, v. 28, n. 1, p. N.PAG, doi. 10.3892/ol.2024.14426
- By:
- Publication type:
- Article
Mechanism of targeting the mTOR pathway to regulate ferroptosis in NSCLC with different EGFR mutations.
- Published in:
- Oncology Letters, 2024, v. 28, n. 1, p. N.PAG, doi. 10.3892/ol.2024.14431
- By:
- Publication type:
- Article
Effectiveness and safety of segmentectomy vs. wedge resection for the treatment of patients with operable non‑small cell lung cancer: A meta‑analysis and systematic review.
- Published in:
- Oncology Letters, 2024, v. 28, n. 1, p. N.PAG, doi. 10.3892/ol.2024.14469
- By:
- Publication type:
- Article
IL-17 induces NSCLC cell migration and invasion by elevating MMP19 gene transcription and expression through the interaction of p300-dependent STAT3-K631 acetylation and its Y705-phosphorylation.
- Published in:
- Oncology Research, 2024, v. 32, n. 4, p. 625, doi. 10.32604/or.2023.031053
- By:
- Publication type:
- Article
Blood-based molecular and cellular biomarkers of early response to neoadjuvant PD-1 blockade in patients with non-small cell lung cancer.
- Published in:
- Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-024-03412-3
- By:
- Publication type:
- Article
Systemic treatment options for non-small cell lung cancer after failure of previous immune checkpoint inhibitors: a bayesian network meta-analysis based on randomized controlled trials.
- Published in:
- BMC Immunology, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12865-024-00633-z
- By:
- Publication type:
- Article
NFIC mediates m6A mRNA methylation to orchestrate transcriptional and post-transcriptional regulation to represses malignant phenotype of non-small cell lung cancer cells.
- Published in:
- Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-024-03414-1
- By:
- Publication type:
- Article
Cost-effectiveness of sotorasib as a second-line treatment for non-small cell lung cancer with KRASG<sup>12C</sup> mutation in China and the United States.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1348688
- By:
- Publication type:
- Article
Farnesyltransferase inhibition overcomes oncogene-addicted non-small cell lung cancer adaptive resistance to targeted therapies.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-49360-4
- By:
- Publication type:
- Article
CT-based quantification of intratumoral heterogeneity for predicting pathologic complete response to neoadjuvant immunochemotherapy in non-small cell lung cancer.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1414954
- By:
- Publication type:
- Article
Case report of QT interval prolongation induced by anamorelin in an obese patient with non-small cell lung cancer.
- Published in:
- Journal of Pharmaceutical Health Care & Sciences, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40780-024-00356-8
- By:
- Publication type:
- Article
Association of potentially inappropriate medications with prognosis among older patients with non-small cell lung cancer.
- Published in:
- BMC Geriatrics, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12877-024-05138-3
- By:
- Publication type:
- Article
Thoracic lymphangitis as an immune-related adverse event: a case report.
- Published in:
- BMC Pulmonary Medicine, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12890-024-03123-5
- By:
- Publication type:
- Article
Frequency-dependent selection of neoantigens fosters tumor immune escape and predicts immunotherapy response.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-06460-7
- By:
- Publication type:
- Article
Single institution experience of MRI-guided radiotherapy for thoracic tumors and clinical characteristics impacting treatment duty cycle.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1401703
- By:
- Publication type:
- Article
The current landscape, advancements, and prospects in the treatment of patients with EGFR exon 20 insertion mutations warrant scientific elucidation.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1367204
- By:
- Publication type:
- Article
The incidence of drug-induced interstitial lung disease caused by epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors in patients with non-small cell lung cancer in presence and absence of vascular endothelial growth factor inhibitors: a systematic review
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1419256
- By:
- Publication type:
- Article
Perspectives of patients with advanced or metastatic non-small cell lung cancer on symptoms, impacts on daily activities, and thresholds for meaningful change: a qualitative research study.
- Published in:
- Frontiers in Psychology, 2024, p. 1, doi. 10.3389/fpsyg.2023.1217793
- By:
- Publication type:
- Article
Lu's approach for video-assisted thoracoscopic surgery.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0300632
- By:
- Publication type:
- Article
Prognostic significance of programmed cell death ligand 1 blood markers in non-small cell lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1400262
- By:
- Publication type:
- Article
Towards a survival risk prediction model for metastatic NSCLC patients on durvalumab using whole-lung CT radiomics.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1383644
- By:
- Publication type:
- Article
Clinical significance and biological function of interferon regulatory factor 1 in non-small cell lung cancer.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1413699
- By:
- Publication type:
- Article
Cost-effectiveness of durvalumab plus tremelimumab in combination with chemotherapy for the treatment of metastatic non-small-cell lung cancer from the US healthcare sector's and societal perspectives.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1256992
- By:
- Publication type:
- Article
Investigation of mediastinal lymph node dissection in clinical stage IA pure-solid non-small cell lung cancer patients.
- Published in:
- Journal of Cardiothoracic Surgery, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13019-024-02839-z
- By:
- Publication type:
- Article
Survival outcomes of segmentectomy and lobectomy for early stage non-small cell lung cancer: a systematic review and meta-analysis.
- Published in:
- Journal of Cardiothoracic Surgery, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13019-024-02832-6
- By:
- Publication type:
- Article
Editorial: Real-world data and real-world evidence in lung cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1436077
- By:
- Publication type:
- Article
CD248-expressing cancer-associated fibroblasts induce epithelial–mesenchymal transition of non-small cell lung cancer via inducing M2-polarized macrophages.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-65435-0
- By:
- Publication type:
- Article
Case report: Sustained remission after combined sintilimab, anti-VEGF therapy, and chemotherapy in a patient with non-small cell lung cancer harboring acquired EGFR 19Del/ T790M/cis-C797S mutation resistance.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1298389
- By:
- Publication type:
- Article
NIR-responsive CN-Pt-GEM hydrogel induces necroptosis and immunotherapeutic responses prevent postoperative recurrence and wound infection in lung carcinoma.
- Published in:
- Journal of Nanobiotechnology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12951-024-02568-4
- By:
- Publication type:
- Article
Progression patterns, resistant mechanisms and subsequent therapy for ALK-positive NSCLC in the era of second-generation ALK-TKIs.
- Published in:
- Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-05388-0
- By:
- Publication type:
- Article
Salvage surgery following tyrosine kinase inhibitor treatment for advanced non-small cell lung cancer.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Further knowledge and developments in resistance mechanisms to immune checkpoint inhibitors.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1384121
- By:
- Publication type:
- Article
Post-marketing safety of lorlatinib: a real-world study based on the FDA adverse event reporting system.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1385036
- By:
- Publication type:
- Article
Case report: EGFR-TKI rechallenge after osimertinib-induced interstitial lung disease: a case report and literature review.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1410684
- By:
- Publication type:
- Article
Spatial iTME analysis of KRAS mutant NSCLC and immunotherapy outcome.
- Published in:
- NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00626-6
- By:
- Publication type:
- Article